The Nucleic Acid-based Therapeutics Market Share demonstrated robust performance with a valuation of USD 5.3 billion, projecting substantial growth as it targets USD 13.50 billion by 2030. This anticipated expansion signifies a remarkable Compound Annual Growth Rate (CAGR) of 12.4% over the forecast period spanning from 2023 to 2030. Nucleic acid-based therapeutics, including RNA...